[Experience with sulodexide (Vessel Due F) in diabetics with ischemic disease of the lower extremities].
A total of nine patients with diabetes type I and II and with claudications due to macro- and microangiopathies of the lower extremities took sulodexide (Vessel Due F) by the i.m. route for a period of 20 days and then as capsules for 90 days. In all a favourable therapeutic effect was recorded, in particular as regards delay of claudications. The authors recorded lower blood sugar values, lower levels of cholesterol, triglycerides, fibrinogen and plasma viscosity. In the authors' view sulodexide is an important advance in the treatment of diabetics with claudications.
Utratová
J
J
II. interní klinika FNsP Brno-Bohunice.
Mayer
J
J
Elbl
L
L
Vorlícek
J
J
Prásek
J
J
D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy; D001809:Blood Viscosity; D003925:Diabetic Angiopathies / Q000097:blood / Q000188:drug therapy*; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007511:Ischemia / Q000097:blood / Q000188:drug therapy*; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged
D006025:Glycosaminoglycans; D000960:Hypolipidemic Agents; C007858:glucuronyl glucosamine glycan sulfate
Zkusenosti s prípravkem sulodexide (Vessel Due F) u diabetikû s ischemickou chorobou dolních koncetin.